Atossa Therapeutics, Inc. Common Stock (ATOS) is a publicly traded Healthcare sector company. As of May 20, 2026, ATOS trades at $5.00 with a market cap of $41.16M and a P/E ratio of -1.20. ATOS moved +2.00% today. Year to date, ATOS is -47.72%; over the trailing twelve months it is -65.75%. Its 52-week range spans $3.76 to $24.90. Analyst consensus is strong buy with an average price target of $23.00. Rallies surfaces ATOS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ATOS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ATOS recently traded at $5.00. Market cap is $41.16M. P/E ratio is -1.20. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $5.00 |
| Market Cap | $41.16M |
| P/E Ratio | -1.20 |
| EPS | $-4.04 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.90 |
| 52-Week Low | $3.76 |
| Volume | 36.52K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-34.77M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-34.77M | $-4.04 |
| 2024 | $0 | $-25.50M | $-0.20 |
| 2023 | $0 | $-30.09M | $-0.24 |
| 2022 | $0 | $-26.96M | $-0.21 |
3 analysts cover ATOS: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $23.00.